Dr. Maria E. Rodrigo

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Endomyocardial Fibrosis. Her top areas of expertise are Primary Localized Cutaneous Amyloidosis, Cardiac Amyloidosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, and Cardiac Ablation.

Khalid Ashai is a Cardiologist in Greenbelt,, Maryland. Dr. Ashai is rated as a Distinguished provider by MediFind in the treatment of Endomyocardial Fibrosis. His top areas of expertise are Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Endoscopy.

Christopher Sibley is a Cardiologist in Bethesda,, Maryland. Dr. Sibley is rated as an Advanced provider by MediFind in the treatment of Endomyocardial Fibrosis. His top areas of expertise are Atherosclerosis, Metabolic Syndrome, Coronary Heart Disease, Endomyocardial Fibrosis, and Hormone Replacement Therapy (HRT).